30.01
price down icon0.66%   -0.20
after-market アフターアワーズ: 30.01
loading
前日終値:
$30.21
開ける:
$30.39
24時間の取引高:
21,608
Relative Volume:
0.89
時価総額:
$355.72M
収益:
$9.71M
当期純損益:
$-29.96M
株価収益率:
-11.16
EPS:
-2.69
ネットキャッシュフロー:
$-14.79M
1週間 パフォーマンス:
-3.69%
1か月 パフォーマンス:
+2.07%
6か月 パフォーマンス:
+17.64%
1年 パフォーマンス:
+87.91%
1日の値動き範囲:
Value
$29.50
$31.08
1週間の範囲:
Value
$29.09
$32.50
52週間の値動き範囲:
Value
$14.33
$33.78

Xoma Royalty Corp Stock (XOMA) Company Profile

Name
名前
Xoma Royalty Corp
Name
セクター
Healthcare (1196)
Name
電話
510-204-7239
Name
住所
2200 POWELL STREET, EMERYVILLE, CA
Name
職員
13
Name
Twitter
@xomacorp
Name
次回の収益日
2024-11-05
Name
最新のSEC提出書
Name
XOMA's Discussions on Twitter

XOMA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
XOMA 30.01 355.72M 9.71M -29.96M -14.79M -2.69
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2021-09-07 ダウングレード Wedbush Outperform → Neutral
2021-06-29 開始されました Aegis Capital Buy
2021-01-19 繰り返されました H.C. Wainwright Buy
2018-01-18 繰り返されました H.C. Wainwright Buy
2017-10-17 再開されました H.C. Wainwright Buy
2017-09-05 アップグレード Wedbush Neutral → Outperform
2017-06-12 開始されました H.C. Wainwright Buy
2016-11-14 ダウングレード Wedbush Outperform → Neutral
2016-03-11 繰り返されました Wedbush Outperform
2015-07-23 ダウングレード Jefferies Buy → Hold
2015-07-22 ダウングレード Ladenburg Thalmann Buy → Neutral
2015-07-22 ダウングレード Piper Jaffray Overweight → Neutral
2014-10-10 再開されました ROTH Capital Buy
2014-04-29 アップグレード MLV & Co Hold → Buy
2014-03-11 ダウングレード MLV & Co Buy → Hold
2014-03-05 繰り返されました Ladenburg Thalmann Buy
2013-10-31 繰り返されました MLV & Co Buy
2013-05-09 繰り返されました Ladenburg Thalmann Buy
2012-05-14 開始されました Cowen & Co Outperform
2011-03-31 繰り返されました MLV Capital Buy
2011-03-23 繰り返されました RBC Capital Mkts Outperform
2011-01-06 繰り返されました Ladenburg Thalmann Buy
2011-01-04 繰り返されました Wedbush Outperform
すべてを表示

Xoma Royalty Corp (XOMA) 最新ニュース

pulisher
Nov 16, 2024

Short Interest in XOMA Co. (NASDAQ:XOMA) Drops By 23.5% - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

XOMA Co. (NASDAQ:XOMA) Sees Large Decrease in Short Interest - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Xoma CEO Owen Hughes sells $655,335 in stock - Investing.com India

Nov 14, 2024
pulisher
Nov 13, 2024

Xoma royalty corp CFO Thomas Burns sells shares worth $292,663 - Investing.com

Nov 13, 2024
pulisher
Nov 11, 2024

What Makes XOMA Royalty (XOMA) a New Buy Stock - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

XOMA Royalty Reports Third Quarter 2024 Financial Results and Recent Activities - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

What is HC Wainwright's Forecast for XOMA FY2025 Earnings? - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

XOMA Royalty Corporation (NASDAQ:XOMA) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates - Yahoo Finance

Nov 10, 2024
pulisher
Nov 09, 2024

XOMA Royalty Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

XOMA Royalty’s Third Quarter 2024 Financial Insights - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

XOMA Royalty: Q3 Earnings Snapshot - CT Insider

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Royalty (XOMA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities - ForexTV.com

Nov 07, 2024
pulisher
Nov 07, 2024

Xoma reports Q3 EPS ($1.59), consensus (44c) - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Royalty Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

XOMA Reports Mixed Q3: FDA Approval Win Despite $17.2M Loss, Expands Portfolio | XOMA Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

XOMA stock soars to 52-week high, reaching $32 By Investing.com - Investing.com UK

Nov 06, 2024
pulisher
Nov 06, 2024

XOMA stock soars to 52-week high, reaching $32 - Investing.com

Nov 06, 2024
pulisher
Nov 05, 2024

XOMA (NASDAQ:XOMA) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

XOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s Why - Defense World

Nov 05, 2024
pulisher
Oct 30, 2024

XOMA Royalty Corporation's (NASDAQ:XOMA) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week - Simply Wall St

Oct 30, 2024
pulisher
Oct 29, 2024

XOMA stock soars to 52-week high, reaching $30.7 By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

XOMA stock soars to 52-week high, reaching $30.7 - Investing.com India

Oct 29, 2024
pulisher
Oct 27, 2024

XOMA’s (XOMA) Buy Rating Reaffirmed at HC Wainwright - Defense World

Oct 27, 2024
pulisher
Oct 26, 2024

XOMA Co. (NASDAQ:XOMAO) Short Interest Down 40.0% in October - Defense World

Oct 26, 2024
pulisher
Oct 23, 2024

Twist Bioscience enters into purchase agreement with XOMA Royalty - MSN

Oct 23, 2024
pulisher
Oct 23, 2024

XOMA (NASDAQ:XOMA) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Oct 23, 2024
pulisher
Oct 22, 2024

XOMA Royalty Corporation Acquires 50% of Twist's Existing Royalty and Milestone Economics for $15 Million - Marketscreener.com

Oct 22, 2024
pulisher
Oct 22, 2024

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience - The Manila Times

Oct 22, 2024
pulisher
Oct 22, 2024

XOMA Royalty Significantly Expands its Royalty and - GlobeNewswire

Oct 22, 2024
pulisher
Oct 22, 2024

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash - The Bakersfield Californian

Oct 22, 2024
pulisher
Oct 21, 2024

Investors in XOMA Royalty (NASDAQ:XOMA) have seen favorable returns of 72% over the past year - Yahoo Finance

Oct 21, 2024
pulisher
Oct 19, 2024

Ellsworth Advisors LLC Makes New $516,000 Investment in XOMA Co. (NASDAQ:XOMA) - MarketBeat

Oct 19, 2024
pulisher
Oct 17, 2024

XOMA stock soars to 52-week high, reaching $30.49 - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

XOMA stock soars to 52-week high, reaching $30.49 By Investing.com - Investing.com South Africa

Oct 17, 2024
pulisher
Oct 15, 2024

XOMA Royalty's Preferred Shares: High-Yield Dividends From Biotech Royalties (NASDAQ:XOMA) - Seeking Alpha

Oct 15, 2024
pulisher
Oct 09, 2024

XOMA (NASDAQ:XOMA) Share Price Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat

Oct 09, 2024
pulisher
Oct 01, 2024

XOMA Co. (NASDAQ:XOMA) is Stonepine Capital Management LLC’s 6th Largest Position - Defense World

Oct 01, 2024
pulisher
Sep 29, 2024

PIMCO Strategic Income Fund, XOMA Corporation, Another 2 Companies Have A High Estimated Dividend Yield - Via News Agency

Sep 29, 2024
pulisher
Sep 29, 2024

Rhumbline Advisers Raises Stock Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World

Sep 29, 2024
pulisher
Sep 28, 2024

XOMA (NASDAQ:XOMA) Shares Pass Above 200-Day Moving Average of $25.91 - Defense World

Sep 28, 2024
pulisher
Sep 28, 2024

XOMA (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving Average of $25.91 - MarketBeat

Sep 28, 2024
pulisher
Sep 24, 2024

XOMA Co. (NASDAQ:XOMAO) Announces $0.52 Quarterly Dividend - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

XOMA shares hold as analyst reiterates Buy rating post-FDA nod - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

XOMA Royalty gains FDA-approved asset for NPC By Investing.com - Investing.com Canada

Sep 23, 2024
pulisher
Sep 23, 2024

XOMA Royalty gains FDA-approved asset for NPC - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

XOMAOXOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock Latest Stock News & Market Updates - StockTitan

Sep 23, 2024
pulisher
Sep 23, 2024

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. - GlobeNewswire

Sep 23, 2024
pulisher
Sep 23, 2024

Xoma notes FDA approval of Zevra’s MIPLYFFA in patients with NPC - TipRanks

Sep 23, 2024

Xoma Royalty Corp (XOMA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
大文字化:     |  ボリューム (24 時間):